Tema Oncology ETF (CANC) Chart & Stock Price History → LEAKED: Jeff Bezos' $330 Million Gamble (From Behind the Markets) (Ad) Free CANC Stock Alerts $26.75 +0.02 (+0.07%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsRatingsTrendsStock AnalysisChartDividendHoldingsRatingsTrends Tema Oncology ETF Stock Price Performance5 Day Performance-1.18%1 Month Performance-0.48%3 Month Performance-6.76%6 Month Performance+9.23%Year-To-Date Performance+1.34% Receive CANC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. CANC Stock Chart for Saturday, June, 1, 2024 CANC Chart by TradingView Tema Oncology ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$26.73$26.75+0.07%$26.98$26.6313,581 shs$18.19 million05/30/2024$26.46$26.73+1.02%$27.37$26.6415,829 shs$18.18 million05/29/2024$26.76$26.46-1.12%$26.73$26.3146,723 shs$17.99 million05/28/2024$27.07$26.76-1.15%$27.00$26.6027,196 shs$18.20 million05/27/2024$27.07$27.07+0.01%$27.50$26.9743,200 shs$18.41 million05/24/2024$26.99$27.07+0.31%$27.50$26.9743,296 shs$18.41 million Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$27.45$26.99-1.69%$28.00$26.8018,386 shs$18.35 million05/22/2024$27.44$27.45+0.04%$27.81$27.3210,284 shs$18.67 million05/21/2024$27.48$27.44-0.15%$27.59$27.3210,791 shs$18.66 million05/20/2024$27.44$27.48+0.14%$27.55$27.482,184 shs$18.69 million05/17/2024$27.63$27.44-0.69%$27.54$27.442,566 shs$18.66 million05/16/2024$27.73$27.63-0.37%$27.75$27.632,464 shs$18.79 million05/15/2024$27.30$27.73+1.59%$27.74$27.681,491 shs$18.86 million05/14/2024$27.23$27.30+0.25%$27.44$27.232,137 shs$18.56 million05/13/2024$26.93$27.23+1.12%$27.41$27.23235 shs$18.52 million05/10/2024$27.15$26.93-0.81%$26.93$26.863,621 shs$18.31 million05/09/2024$27.02$27.15+0.48%$27.22$27.14878 shs$18.46 million05/08/2024$27.41$27.02-1.42%$27.16$27.022,125 shs$18.37 million05/07/2024$27.48$27.41-0.25%$27.45$27.335,107 shs$18.64 million05/06/2024$27.57$27.48-0.33%$27.48$27.47278 shs$18.69 million05/03/2024$27.38$27.57+0.69%$27.57$27.576 shs$18.75 million05/02/2024$26.88$27.38+1.86%$27.38$27.20124 shs$18.62 million05/01/2024$26.57$26.88+1.17%$27.28$26.88430 shs$18.28 million04/30/2024$26.62$26.57-0.19%$26.67$26.57457 shs$18.07 million04/29/2024$25.94$26.62+2.62%$26.62$26.31331 shs$18.10 million04/26/2024$25.47$25.94+1.85%$25.94$25.84207 shs$17.64 million04/25/2024$25.87$25.47-1.55%$25.47$25.4749 shs$17.32 million04/24/2024$26.01$25.87-0.54%$26.00$25.87229 shs$17.59 million04/23/2024$25.69$26.01+1.25%$26.01$26.0111 shs$17.69 million04/22/2024$25.27$25.69+1.66%$25.69$25.6920 shs$17.47 million04/19/2024$25.44$25.27-0.67%$25.27$25.26122 shs$17.18 million04/18/2024$25.56$25.44-0.47%$25.63$25.44242 shs$17.30 million04/17/2024$25.67$25.56-0.43%$25.73$25.56566 shs$17.38 million04/16/2024$25.91$25.67-0.93%$25.67$25.65678 shs$17.46 million04/15/2024$26.25$25.91-1.30%$25.91$25.91199 shs$17.62 million04/12/2024$26.93$26.25-2.53%$26.33$26.25484 shs$17.85 million04/11/2024$26.82$26.93+0.41%$26.94$26.71378 shs$18.31 million04/10/2024$27.32$26.82-1.83%$26.87$26.82202 shs$18.24 million04/09/2024$26.99$27.32+1.22%$27.32$27.242,013 shs$18.58 million04/08/2024$27.03$26.99-0.15%$26.99$26.94410 shs$18.35 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”04/05/2024$26.97$27.03+0.22%$27.03$27.03174 shs$18.38 million04/04/2024$27.33$26.97-1.32%$27.09$26.97312 shs$18.07 million04/03/2024$27.41$27.33-0.29%$27.39$27.33555 shs$18.31 million04/02/2024$27.94$27.41-1.90%$27.55$27.41179 shs$18.37 million04/01/2024$28.12$27.94-0.63%$28.00$27.633,292 shs$18.72 million03/29/2024$28.12$28.12$28.12$27.981,550 shs$18.84 million03/28/2024$27.89$28.12+0.82%$28.12$27.981,550 shs$18.84 million03/27/2024$27.35$27.89+1.97%$27.91$27.82232 shs$18.69 million03/26/2024$27.28$27.35+0.26%$27.45$27.35651 shs$18.32 million03/25/2024$27.48$27.28-0.71%$27.53$27.282,126 shs$18.28 million03/22/2024$27.75$27.48-0.97%$27.50$27.471,042 shs$18.41 million03/21/2024$27.69$27.75+0.22%$27.84$27.75388 shs$18.59 million03/20/2024$27.48$27.69+0.76%$27.69$27.502,277 shs$18.55 million03/19/2024$26.85$27.48+2.35%$27.49$27.47641 shs$18.41 million03/18/2024$27.14$26.85-1.07%$27.35$26.852,412 shs$17.99 million03/15/2024$27.15$27.14-0.04%$27.24$27.11359 shs$18.18 million03/14/2024$27.78$27.15-2.27%$27.15$27.1535 shs$18.19 million03/13/2024$27.88$27.78-0.36%$27.80$27.78265 shs$18.61 million03/12/2024$28.05$27.88-0.61%$27.88$27.8829 shs$18.68 million03/11/2024$28.16$28.05-0.39%$28.05$28.0590 shs$18.79 million03/08/2024$28.16$28.16$28.16$28.169 shs$18.87 million03/07/2024$28.10$28.16+0.21%$28.21$28.16677 shs$18.87 million03/06/2024$28.05$28.10+0.18%$28.10$28.1084 shs$18.83 million03/05/2024$28.28$28.05-0.81%$28.05$28.05222 shs$18.79 million03/04/2024$28.69$28.28-1.43%$28.28$28.28127 shs$18.95 million03/01/2024$28.21$28.69+1.70%$28.69$28.69171 shs$19.22 million02/29/2024$28.72$28.21-1.78%$28.41$28.21455 shs$18.90 million Related Companies: GXTG Stock Price Chart NERD Stock Price Chart WISE Stock Price Chart SPAQ Stock Price Chart SETM Stock Price Chart EQRR Stock Price Chart MOOD Stock Price Chart TMET Stock Price Chart BKIV Stock Price Chart EMIF Stock Price Chart Receive CANC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CANC) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.